Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month
研究领域：
Metabolic Disease
Target：
IC50: 0.9 nM (GSK-3α), 5 nM (GSK-3β)[4]
描述：
AZD2858 is a potent, orally active GSK-3 inhibitor, with IC50 of 0.9 and 5 nM for GSK-3α and GSK-3β, respectively, used in the research of fracture healing.
m.cnreagent.com
